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Colorectal cancer is the fourth most common cancer and the second
most common cause of cancer deaths in the United States where
the vast majority of cases occurs over age 60 years (Greenlee
et al, 2000). In contrast, this disease is uncommon in developing
countries (Magrath and Litvak, 1993), including Egypt where it is
only the fifth most common cause of cancer deaths (Soliman et al,
1999). However, the percentage of young-onset colorectal cancer
cases in Egyptians is strikingly high with more than one third of cases
occurring under age 40 years, and the age-adjusted mortality rates in
young Egyptians are likewise high (Soliman et al, 1997a, 1999). In
addition, rectal cancer is frequent (Soliman et al, 1997a, 1999). 
We have conducted a series of studies to characterize the
distinctive distribution of age and anatomic location and to explore
the possible risk factors for colorectal cancer in Egypt. We
reported previously that the unusual disease pattern may be related
to 2 major groups of risk factors: heavy environmental exposures
such as organochlorine pesticides (Soliman et al, 1997b) and
inherited genetic factors including familial aggregation (Soliman
et al, 1998b), hereditary nonpolyposis colorectal cancer (HNPCC),
and defective expression of mismatch repair genes (Soliman et al,
1998a). Schistosomiasis, particularly due to S. japonicum, has
been implicated as an aetiologic factor in colorectal cancer (Chen
et al, 1981; International Agency for Research on Cancer, 1994),
and bilharziasis is common in Egypt (El-Khoby et al, 2000). 
Recent advances in molecular biology have revealed numerous
genetic alterations involved in colorectal tumorigenesis (Kinzler
and Vogelstein, 1996; Gryfe et al, 1997; Ilyas et al, 1999). The
development of most colorectal carcinomas begins with inactiva-
tion of the APC (adenomatous polyposis coli) suppressor gene/β -
catenin pathway. Clonal accumulation of alterations then occurs,
including activation of proto-oncogenes such as K-ras, and inacti-
vation of additional suppressor genes. The genes commonly in-
activated during progression include the p53 gene on the short
arm of chromosome 17 (Levine, 1997; Ding and Fisher, 1998).
Mutated p53 gene product fails to regulate normally a variety of
genes regulated by wild-type p53 (Cox, 1997). For many
suppressor genes, including p53, inactivation of one allele is often
caused by loss due to chromosomal instability of all or part of the
chromosome where the gene resides, and allelic losses throughout
the genome are common (Lengauer et al, 1998). 
About 15% of sporadic colorectal cancers are distinguished by
nucleotide insertions or deletions in numerous, intrinsically unstable
repeated sequences in tumour DNA, termed microsatellite insta-
bility (MSI), also termed ubiquitous somatic mutations, DNA repli-
cation errors/RER, or nucleotide instability (Jiricny, 1998; Lengauer
et al, 1998; Prolla, 1998). A workshop sponsored by the National
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cation of MSI in colorectal cancers (Boland et al, 1998). Tumours
with high levels of MSI (MSI-H) are characteristic of hereditary
nonpolyposis colorectal cancer syndrome (HNPCC), and MSI
testing provides a sensitive diagnostic indicator of patients with the
syndrome, although most MSI-H tumours in older patients are
sporadic (Boland et al, 1998). MSI-H also occurs at high frequency
in young patients with presumably sporadic colorectal cancer (Liu
et al, 1995; Lukish et al, 1998; Chan et al, 1999). 
HNPCC is caused by germline mutation of one of a group of
DNA mismatch repair genes followed by somatic inactivation of
the other allele (Lynch and Lynch, 2000). Abnormalities of the
hMLH1 gene or hMSH2 gene are responsible for most HNPCC
cases, and loss in tumours of immunohistochemical nuclear
expression of the products of these genes often indicates which
gene is mutated in the germline (Dietmaier et al, 1997; Fujiwara
et al, 1998; Dieumegard et al, 2000; Muller et al, accepted). By
contrast, sporadic MSI-H tumours usually occur due to somatic
inactivation of both alleles of the hMLH1 mismatch repair gene,
most commonly via transcriptional silencing which results from
aberrant methylation of cytosines in the cytosine- and guanine-rich
promoter region with loss of nuclear immunohistochemical
expression of the gene product (Kane et al, 1997; Herman et al,
1998; Kuismanen et al, 2000). The genetic alterations which accu-
mulate during progression of both hereditary and sporadic
neoplasms characterized by MSI-H include mutations in genes
with microsatellites within the coding region, such as the type II
receptor for transforming growth factor β 1 (TGFβ 1RII) (Parsons
et al, 1995; Fujiwara et al, 1998; Akhurst and Balmain, 1999; Abe
and Masuda, 2000; Calin et al, 2000). Allelic deletions which are
frequent in microsatellite-stable cancers are rare in MSI-H cancers
(Fujiwara et al, 1998; Lengauer et al, 1998). Colorectal carci-
nomas with low levels of MSI (MSI-L) are uncommon and appear
to arise through a pathway which differs from MSI-H and
microsatellite-stable tumours, possibly involving hyperplastic
polyps as a precursor (Iino et al, 1999; Jass et al, 1999). 
The molecular pathology of colorectal carcinoma in Egypt has
not been reported. We, therefore, studied the profile of patholog-
ical and molecular characteristics of colorectal cancers in patients
from this country where adverse environmental exposures are high
and genetic factors are known to be important (Soliman et al,
1997b, 1998a, 1998b). We analysed specimens from 59 Egyptian
colorectal cancer cases for MSI status, methylation of the hMLH1
promoter, loss of expression of hMSH2 gene product, K-ras gene
mutation in codons 12 and 13, and p53 gene product overexpres-
sion of the type seen with p53 gene mutation. We compared the
molecular pathology to Western patients with sporadic, young-
onset or HNPCC-associated colorectal cancer previously
published from our laboratory (Jen et al, 1994a; Fujiwara et al,
1998; Lukish et al, 1998). 
MATERIALS AND METHODS 
Egyptian tumour specimens and patients 
Paraffin-embedded blocks of unbuffered formalin-fixed colorectal
carcinomas from 59 consecutive patients were included in this
study. These patients participated in our previous study on familial
aggregation of colorectal cancer in Egypt (Soliman et al, 1998b)
and had their resection in 1996 and 1997 at the National Cancer
Institute in Cairo (n = 37) or Tanta Cancer Center in the mid Nile
River Delta region (n = 22). The study was approved by the insti-
tutional review boards at the MD Anderson Cancer Center and
The Johns Hopkins Medical Institutions and was performed in
accordance with filed institutional assurances. Information on
demographics, residence, family history, tumour site and stage
were retrieved from the medical records, pathology reports and our
previous epidemiologic studies. Patients with familial adenoma-
tous polyposis were excluded. 
Patient age ranged from 10 to 72 years (mean 42.8 ± SD 15.1),
and the series included 34 males (58%) and 25 females. All
patients had stage II or stage III colorectal carcinoma. The resi-
dence of most patients was rural (78%). 27% of the patients were
offspring of consanguineous marriages of first cousins. The study
group was representative of our previous national study of 1608
colorectal cancer patients in Egypt (Soliman et al, 1997a), with no
statistically significant differences in age, gender, residence or
frequency of rectal cancer. 
For each case, the histopathologic diagnosis of colorectal cancer
was confirmed, and tumour differentiation and mucinous (colloid)
and signet-ring cell histology were recorded based on criteria used
in our previous studies (Jen et al, 1994a; Kim et al, 1994). All
blocks of tumour tissue, nearby mucosa and distant surgical
margins were serially sectioned (5 serials, 20 µ m apart) for evalu-
ation of schistosomal infection. Criteria included the presence of
intact or calcified ova, active granulomas or worms. Speciation of
schistosoma on the basis of morphology was not attempted. 
Comparison groups of Western patients 
Previously published data for comparison with the Egyptian carci-
nomas were available from 3 groups of colorectal carcinomas
analysed in our laboratory: (1) sporadic colorectal cancers (n = 145)
from stage II and III patients at The Johns Hopkins Hospital
enrolled in a study of prognostic markers (Jen et al, 1994a); (2)
young-onset colorectal cancers in patients under age 40 years 
(n = 36) from a study at the National Naval Medical Center
in Bethesda, Maryland (Lukish et al, 1998); and (3) HNPCC-
associated colorectal cancers (n= 39) from American, Canadian, and
New Zealand patients in 20 families (Fujiwara et al, 1998) that met
the International Collaborative Group criteria for HNPCC (Vasen
et al, 1991) and/or had germline mutation of hMSH2 or hMLH1
mismatch repair genes (Wijnen et al, 1997; Genuardi et al, 1998). 
Microdissection and DNA extraction 
For all 59 Egyptian tumours, areas of carcinoma and non-
neoplastic tissue were microdissected from numbered tissue
sections. Cellular tumour that contained few stromal and inflam-
matory cells was selected. Multiple areas with high cellularity
from each slide were combined to enhance the detection of clonal
abnormalities. DNA was extracted as in our previous studies (Jen
et al, 1994a; Moskaluk and Kern, 1997; Fujiwara et al, 1998;
Lukish et al, 1998). 
Assay for microsatellite instability (MSI) 
All molecular and immunohistochemical analyses were done without
access to clinical data. MSI was evaluated by polymerase chain reac-
tion (PCR) amplification of 8 non-coding polymorphic dinucleotide
repeat sequences, 2 non-coding rarely polymorphic polyadenine
tracts (BAT26 and BAT25), and 1 coding rarely polymorphic
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receptor gene (TGFβ1 RII), as in our previous studies (Jen et al,
1994a, 1994b; Parsons et al, 1995; Fujiwara et al, 1998). The 8 dinu-
cleotide repeat sequences included 5 on the long arm of chromosome
18 (D18S69, D18S64, D18S55, D18S61, and D18S58 from
centromere to telemere), 2 on the long arm of chromosome 5
(D5S107 and D5S346), and 1 on the short arm of chromosome 2
(D2S123). 
The normal alleles were represented by 1 (non-polymorphic) or 2
(polymorphic) major bands accompanied by a few minor bands. The
mobility shift of PCR products from tumour DNA as compared with
corresponding non-neoplastic tissue DNA was determined for each
marker independently. Each tumour was classified from the aggre-
gated marker results as: (1) high levels of MSI (MSI-H) if at least 2
markers representing at least 30% of informative dinucleotide or
mononucleotide markers were shifted (Boland et al, 1998) and/or
mutation was present in TGFβ1 RII (Dietmaier et al, 1997; Perucho,
1999); (2) low levels of MSI (MSI-L) if only 1 marker among a
minimum of 5 dinucleotide and mononucleotide markers was
shifted; (3) microsatellite-stable if no marker among a minimum of
5 informative markers was shifted; (4) indeterminate for MSI if 3 or
fewer markers without shift were informative. 
Assay for methylation of hMLH1 promoter 
Somatic and germline mechanisms leading to MSI were evaluated.
Somatic methylation of the promoter of the hMLH1 mismatch repair
gene is associated with transcriptional silencing of this gene and
resultant MSI-H. The methylation status of hMLH1 in Egyptian
carcinomas with known MSI status was determined by bisulfite treat-
ment of DNA followed by methylation-specific polymerase chain
reaction (MSP-PCR) as described (Herman et al, 1996) with modifi-
cation of primers for methylated and unmethylated alleles and
cycling conditions. Detailed protocols are at the website www.mdan-
derson.org/leukemia/methylation/. In brief, 2 µ g of genomic DNA
from microdissected tumour were denatured with sodium hydroxide,
incubated with sodium bisulfite, purified with DNA Cleanup Kit
(Promega), incubated with sodium hydroxide, precipitated with
ammonium acetate and ethanol, washed with ethanol and resus-
pended in distilled water. The primers were: methylated allele, sense
primer: 5′ -GATAGCGATTTTTAACGC-3′ ; methylated allele, anti-
sense primer: 5′ -TCTATAAATTACTAAATCTCTTCG-3′ ; unmethy-
lated allele, sense primer: 5′ -AGAGTGGATAGTGATTTTTAATG-
T-3′ unmethylated allele, antisense primer: 5′ -ACTCTATAAAT-
TACTAAATCTCTTCA-3′ . Cycling conditions were 95˚C for 10
minutes and 40 cycles of 95˚C for 30 seconds and 53˚C for 45
seconds. PCR products for methylated and unmethylated reactions
were electrophoresced on acrylamide gels and visualized by ethidium
bromide staining. Gel photographs were digitized using a BioRad
imager and evaluated by densitometry using the manufacturer’s soft-
ware. The results were expressed as percentage of methylation by
comparing the density of the methylated band relative to the sum of
the methylated and unmethylated bands. Because the sensitivity of
MSP-PCR can lead to overestimation of low levels of methylation,
only loci showing ≥ 10% methylation were considered methylated. 
Immunostaining for hMSH2 and hMLH1 gene products 
Loss of nuclear expression of hMSH2 gene product is strongly
associated with germline mutation of the hMSH2 gene in patients
with HNPCC (Dietmaier et al, 1997; Fujiwara et al, 1998;
Dieumegard et al, 2000; Muller et al, accepted). Loss of hMLH1
gene product can occur with germline mutation of the gene in
HNPCC patients (Muller et al, accepted) and with transcriptional
silencing by somatic methylation (Kane et al, 1997; Herman et al,
1998; Kuismanen et al, 2000). The subset of Egyptian carcinomas
previously characterized for MSI status was evaluated by immuno-
histochemistry after antigen retrieval with citrate buffer. hMSH2
antibody (clone FE11, Oncogene Research Products, Boston, MA)
was used at 1:100 dilution and hMLH1 antibody (clone G18–15,
Pharmingen, San Diego, CA) at 1:30 dilution in the TechMate
1000 automated staining system (Ventana/BioTek Solutions,
Tucson, AZ), similar to our previous studies (Fujiwara et al, 1998).
Each stained slide was evaluated for positive-control staining of
nuclei in epithelial cells at the bases of colorectal crypts and/or
germinal centres of lymphoid nodules. Tumour cell nuclei in the
immediate vicinity of internal positive controls were then inter-
preted for the presence or absence of nuclear staining. As in our
and other previous studies (Fujiwara et al, 1998; Muller et al,
accepted), hMLH1 staining was inconsistent and therefore not
evaluated further. 
Assay for K-ras proto-oncogene mutations 
All possible mutations in codons 12 and 13 of the K-ras proto-
oncogene were determined as in our previous studies (Jen et al,
1994b; Nucci et al, 1997). Exon 1 was amplified, and the result-
ing PCR product from each tumour was sequenced using the
SequiTherm EXCEL II™ DNA sequencing kit (Epicentre
Technologies, Madison, WI). 
Immunostaining for p53 gene product overexpression
and mutation analysis 
Detection of p53 gene product overexpression by immunohisto-
chemistry was used as an indicator of p53 gene mutation. This
method provides about 75% overall accuracy in colorectal
neoplasms owing to the prolonged half life of most mutant
proteins in such tumours (Baas et al, 1994). DO7 mouse mono-
clonal antibody against p53 (Dako, Carpinteria, CA) was used at
1:100 dilution in the TechMate 1000 automated staining system
(Ventana/BioTek Solutions, Tucson, AZ), as in our previous
studies (Moskaluk et al, 1996). p53 labelling index of > 40% in a
discrete region of or entire tumour was considered positive. Exons
5 through 9 of the p53 gene were amplifiable and sequenced as in
our previous studies (Moskaluk et al, 1996) in 3 MSI-H cancers
with p53 gene product overexpression and high-quality DNA. 
Statistical analysis 
Differences in frequencies between the Egyptian group and the
Western groups and between subsets within the Egyptian group
were evaluated by simple contingency table analysis (Fisher’s
exact probability test) using the SAS statistical package
(Statistical Analysis System User’s Guide, 1990) and true
Epistat. P values are two-sided. 
Cluster analysis was performed to identify subgroups of
Egyptian patients who had similar demographic, pathologic and
molecular attributes (Anderberg, 1973). Variables that were
included in this analysis were age (categorized into 2 groups
younger or older than 40 years), sex, residence (urban versus
rural), schistosomiasis (presence or absence of histopathologic
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(4 variables defined by glandular, mucinous, signet-ring cell or
other histopathologic type), MSI status (one variable contrasting
MSI-H versus MSI-L and microsatellite-stable cancers, and
another variable contrasting MSI-L versus MSI-H and microsatel-
lite-stable tumours), K-ras gene mutation, and p53 gene product
overexpression. We first re-scaled the data as a distance measure
using one minus the Jaccard coefficient (Anderberg, 1973).
We used the average linkage cluster analysis method and chose the
number of clusters by evaluating the pseudo t2. In order to create
clusters in a parsimonious manner, we performed the cluster
analysis, evaluated the resulting clusters to identify any variables
that did not vary significantly among the clusters, and then
removed those variables. 
RESULTS 
The Egyptian patients were young, with ages ranging from 10–72
years and with 44% of patients under age 40 (Table 1). The patho-
logic features of the Egyptian colorectal cancers were unusual as
compared to Western patients. About half of the 59 Egyptian carci-
nomas (51%) were located in the rectum (Table 1), as contrasted
with less than 25% in all 3 Western groups (P = 0.009 to < 0.0001,
Table 2). Most Egyptian tumours (58%) were poorly differenti-
ated, and about a third (37%) were mucinous (Figure 1); by
contrast, among Western cases poorly differentiated tumours
were frequent only in HNPCC patients (Table 2). Tumour
histopathology differed between younger and older Egyptians as
well: a significantly larger proportion of tumours from patients
under 40 years of age were mucinous and poorly differentiated
(P = 0.03 and P = 0.009, respectively, Table 3). Schistosomiasis
was evident in tumour and/or adjacent tissue of 32% of patients
and was unrelated to clinical and other pathologic features. 
Consistent with the unusual tumour pathology, the molecular
characteristics of the Egyptian cancers also differed from Western
patients studied in our laboratory (Table 2). MSI-H occurred in 37%
of Egyptian carcinomas. Among the 10 MSI-H cases evaluated with
dinucleotide and mononucleotide markers, the percentage of altered
markers ranged from 33% to 100% with a mean of 61 ± 8% (stan-
dard error) and a median of 47%. 8 of these 10 MSI-H cancers had
informative mononucleotide markers, and all had at least 1 shifted. 4
MSI-H cases were evaluated with mononucleotide markers only. 3
had at least 2 mononucleotide markers shifted, and the fourth had a
mutation in TGFβ1 RII. MSI-H was explained by methylation of the
promoter of the hMLH1 mismatch repair gene in 36% of the cancers
(Table 4, Figure 2), but no loss of nuclear hMSH2 mismatch repair
gene product indicative of germline hMSH2 mutation was found
(Table 4, Figure 3). MSI-L was found in 16% of cancers, based on
shift of 1 of 5 to 1 of 11 informative dinucleotide and mono-
nucleotide markers. 
The frequency of MSI-H tumours in the Egyptian group as a
whole was higher than in the Western sporadic group (37% vs.
13%, P = 0.002) but much lower than the HNPCC group (95%,
P < 0.0001) and not significantly different from the young-onset
group (47%). However, the Egyptian cases were heterogeneous, as
MSI-H cancer was somewhat more commonly seen in older than
younger Egyptian patients (17% vs 46% P = 0.15, Table 3), and in
those from urban areas (50% vs. 22%, P = 0.002). A family history
of a first-degree relative with colorectal cancer was present in only
1 patient with an MSI-H cancer, who was in the older age group
(48 years old). The Egyptian patients had by far the highest
proportion of MSI-H tumours located in the rectum as compared
to the 3 groups of Western patients (36% vs. 0% to 6%, Table 2). 
K-ras mutation was unusual in Egyptian colorectal cancers as
compared with Western patients (11% vs. 28–48%, P = 0.05 to
0.0004, Table 2 and Figure 2). There was a trend toward higher
prevalence of K-ras mutation in older than younger Egyptian
patients (17% vs 0%, P = 0.14, Table 3). p53 overexpression was
somewhat more common in cancers of younger Egyptian patients
compared with older Egyptian patients (57% vs. 39%, Table 3 and
Figure 4), but the difference was not statistically significant. 
When profiles of multiple alterations were considered, the
frequency of MSI-H cancers with K-ras mutation was comparable in
the Egyptian and Western groups, but the frequency of MSI-H
tumours with p53 overexpression of the type seen with p53 gene
mutation was markedly higher among Egyptians (50% vs 0% in the
sporadic group and 5% in the HNPCC group, Table 2). Sequencing
of exons 5–9 of the p53 gene in 3 available MSI-H Egyptian cancers
with p53 gene product overexpression confirmed a mutation in 2 (T
to A transversion in codon 137, nucleotide 410 of exon 5, CTG to
CAG, leu to gln; G to A transition in codon 238, nucleotide 713 of
exon 7, TGT to TAT, cys to tyr). These mutations have been reported
previously in colorectal and other tumours (Hainaut et al, 1998). 
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Table 1 Clinical characteristics of 59 colorectal cancer patients in Egypt 
Characteristic Frequency in % (No.) 
Age (years)
< 40 44 (26) 
40 + 56 (33) 
Gender 
Male 58 (34) 
Female 42 (25) 
Residence 
Rural 78 (46) 
Urban 22 (13) 
Tumour site 
Ascending colon 25 (15) 
Transverse colon 5 (3) 
Descending colon 15 (9) 
Rectosigmoid colon 3 (2) 
Rectum 51 (30) 
Figure 1 Histopathology of Egyptian rectal carcinoma. The tumour has
mucinous adenocarcinoma with malignant epithelium within pools of mucin
(upper right quadrant) and poorly differentiated adenocarcinoma with solid
areas (lower right quadrant) and rudimentary gland formation (left quadrants)
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K-ras gene mutation status. Ova were identified in 50% (8/16) of
the patients with MSI-H cancers and in 67% (4/6) of the MSI-L
patients, but in only 22% (7/32) of the patients with microsatellite-
stable cancers (P = 0.002). Schistosomiasis was also more frequent
among patients whose tumours showed K-ras gene mutation (80%
of the 5 patients whose tumour had K-ras mutation vs. 31% of the
42 patients whose tumour was negative for K-ras mutation, P =
0.05). 
Complete data including K-ras mutation analysis were avail-
able for 46 patients. We therefore performed cluster analyses in
this subset of patients including and excluding those with K-ras
mutation data, and the results were qualitatively similar. Initial
analysis showed no effect of p53 and tumour site in differenti-
ating the clusters, so these variables were dropped from further
analysis. The pseudo t2 statistics for 1 versus 2 clusters were 19.3
and 8.5, suggesting that a model with 2 clusters would adequately
describe the data. The first cluster was composed predominantly
of young men with poorly differentiated carcinomas including
mucinous or signet-ring cell histologies (Table 5). No patient in
this cluster had K-ras mutation. MSI-H was infrequent, although
MSI-L was evident in about 20% of patients, especially those
with schistosomiasis. By contrast, the second cluster included
predominantly older patients with well- or moderately differen-
tiated gland-forming adenocarcinoma and a higher frequency
of MSI-H,  K-ras mutation and schistosomiasis than the first
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Table 2 Comparison of pathology and molecular pathology in colorectal cancers of patients in Egypt and 3 Western
groups 
Egyptians Westerners
Sporadic Young (≤ 40 yrs) HNPCC 
%% % %  
(95% CI) (95% CI) (95% CI) (95% CI) 
n positive/nn positive/nn positive/nn positive/n
examined examined examined examined 
P value P value P value 
Pathology
Rectal cancer 51 19 22 3 
(38–64) (13–26) (10–39) 3 (0–13) 
30/59 27/145 8/36 1/39 
< 0.0001 0.009 < 0.0001 
Poor differentiation 58 15 22 56 
(44–70) (10–22) (10–39) (40–72) 
34/59 22/145 8/36 22/39 
< 0.0001 0.001 0.99 
Mucinous type 37 11 14 Data not available 
(25–51) (6–17) (5–30) 
22/59 16/145 5/36 
< 0.0001 0.02 
Molecular pathology
MSI-H 37 13 47 95 
(22–54) (8–20) (30–65) (83–99) 
14/38 18/137 17/36 37/39 
0.002 0.48 < 0.0001 
K-ras mutation in codon 12 or 13 11 28 48 28 
(4–23) (21–37) (30–67) (15–45) 
5/47 41/145 15/31 11/39 
0.02 0.0004 0.05 
p53 gene product overexpression 46 36 Not done 8 
(33–60) (24–50) (2–21) 
26/56 21/58 3/39 
0.34 <  0.0001 
MSI-H in rectal cancers 36 0 6 3 
(13–65) 0 (0–19) (0–29) (0–14) 
5/14 0/18 1/17 1/37 
0.01 0.07 0.004 
MSI-H and K-ras mutation 23 18 33 31 
(5–54) (4–43) (13–59) (17–49) 
3/13 3/17 6/18 11/35 
0.99 0.70 0.73 
MSI-H and p53 overexpression 50 0 Not done 5 
(23–77) (0–19) (1–18) 
7/14 0/18 2/37 
0.001 0.0007 
BJOC 01-1838 1037-1046  1/10/01  11:55 am  Page 1041cluster. This group had characteristics more similar to colorectal
cancer in Western countries, except for the presence of schistoso-
miasis. 
DISCUSSION 
We report here that the molecular pathology of colorectal carcinoma
in Egypt differs from Western patients, and between younger and
older Egyptians. These findings reinforce the conclusion from our
previous epidemiologic studies (Soliman et al, 1997a, 1999) that the
pathogenesis of colorectal carcinoma in Egypt has unique features.
Although Arabic countries share some cultural background and
environmental exposures (Temtamy et al, 1994; Al-Saleh et al,
1998), rates of young-onset disease are higher in Egypt than in
Jordan (Al-Jaberi et al, 1997), Lebanon (Adib et al, 1998), Algeria
(Parkin et al, 1992), and Saudi Arabia (Isbister, 1992). 
Occurrence of colorectal carcinoma at young age in Egypt could
reflect the presence of clinically inapparent inherited syndromes.
We excluded patients with history of or morphologic evidence of
familial adenomatous polyposis. HNPCC is unlikely because
tumours with loss of hMSH2 gene product of the type seen with
germline hMHS2 mutation were not identified in our study. MSI-H
cancers in young patients suggestive of HNPCC were rare, and
the frequency of family history of colorectal or other HNPCC-
associated cancers was low. In addition, some of the MSI-H
cancers were explained by methylation of the hMLH1 promoter.
There is a high prevalence of consanguinity in Egypt, reflected in
our study group, because of the tradition of interfamilial marriages
(Temtamy et al, 1994), and this cultural characteristic could
contribute to non-syndromic inherited predisposition. 
Poorly differentiated carcinomas with mucinous and signet-ring
cell histology occurred in our first cluster (Table 5) of young
Egyptian patients with low frequency of schistosomiasis. Studies
in Western countries with high risk of colorectal cancer and in
low-risk populations such as the black populations of South Africa
and East Africa have also shown increased frequency of mucinous
histology and rectal cancer in young patients (Bedikian et al, 1981;
Adloff et al, 1986; Peters et al, 1989; Heys et al, 1994; Steele,
1994; Rubin et al, 1998; Boytchev et al, 1999). Epidemiologic
studies indicate that tumour site may be related to specific risk
factors affecting an anatomical segment of the colorectum
(Williams et al, 1977; Weisburger et al, 1980; Peters et al, 1989).
We found, however, that the rectal predominance in Egyptian
cases occurred in both younger and older patients and was
unrelated to urban/rural residence, which is associated with very
different environmental exposures. 
Both microsatellite-stable and MSI-H carcinomas in our series
had unusual molecular genetic characteristics in comparison to
Western tumours. Mutation of the K-ras proto-oncogene was
uncommon in Egyptian colorectal cancers in general, in contrast to
Western cases (Gryfe et al, 1997; Ilyas et al, 1999), and was not
found in any patient under age 40 years in our study. Low frequency
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Table 3 Age-related differences in pathology and molecular pathology in
colorectal cancers of Egyptian patients 
Age (years) 
Tumour  < 40 40+ 
characteristic
% Fraction % Fraction P
Differentiation 
Poor 77 20/26 42 14/33 
0.009 Moderate or well 23 6/26 58 19/33
Mucinous carcinoma 54 14/26 24 8/33 0.03 
MSI-H carcinoma 17 2/12 46 12/26 0.15 
K-ras gene mutation 0 0/18 17 5/29 0.14 
p53 overexpression 57 13/23 39 13/33 0.28 
Table 4 Evaluation of colorectal cancers from Egyptian patients for
mechanisms producing microsatellite instability 
Microsatellite instability status 
MSI-H MSI-L MS Stable 
%% %  
(95% CI) (95% CI) (95% CI) 
Mechanism n positive/nn positive/nn positive/n
examined examined examined 
Loss of nuclear 0 0 0 
hMSH2 gene product (0–31) (0–60) (0–23) 
(germline) 0/10 0/4 0/14 
Methylation of 36 0 0 
hMLH1 promoter 11–69 0–52 0–19 
(somatic) 4/11 0/5 0/18 
T1 T2 T3
TGFβ 1RII
UUU MMM C T G AC TG A
T1 T2 T3 T1 T2
hMLH1 K-ras
Figure 2 Assays for mutation in gene for transforming growth factor beta1
type II receptor (TGFβ1 RII, left panel), methylation of the promoter of the
hMLH1 mismatch repair gene (centre panel), and mutation in codons 12 and
13 of the K-ras proto-oncogene (right panel) in Egyptian colorectal
carcinomas. Polymerase chain reaction (PCR) amplification of the
polyadenine tract of the TGFβ1 RII gene for 3 tumours (lanes T1–T3) shows
wild-type alleles (arrow) in all 3 and a mutated allele with a 2 basepair
deletion in lane T1 (arrowhead). Methylation-specific PCR using primers
specific for methylated (M) and unmethylated (U) alleles in bisulfite-treated
DNA from 3 tumours shows abnormal methylated alleles in lanes T2 and T3
but not T1. Sequencing of PCR products after amplification of K-ras shows a
G to T transversion in the second basepair of codon 12 (arrowhead) in lanes
of T2
Figure 3 Immunohistochemistry of hMSH2 mismatch repair gene product in
Egyptian rectal cancer. The mucinous carcinoma retained nuclear expression
of hMSH2
BJOC 01-1838 1037-1046  1/10/01  11:55 am  Page 1042of K-ras mutation has also been found previously in colorectal carci-
nomas in the low-incidence population in Singapore, with
increasing mutation frequency associated with increasing incidence
in the population in recent years (Tang et al, 1999). K-ras mutation
is also uncommon in rectal carcinomas of Finnish women
(Servomaa et al, 2000). MSI-H cancers are rarely located in the
rectum in Western populations (Boland et al, 1998; Lukish et al,
1998), but fully half of Egyptian MSI-H cases were at that site. MSI-
H carcinomas in our Egyptian series had frequent overexpression of
p53 gene product of the type seen with p53 gene mutation, and
sequencing confirmed the presence of a p53 gene mutation in 2 of 3
informative cases. By contrast, p53 overexpression is uncommon in
MSI-H cancers in a large number of Western series, including our
own (Ionov et al, 1993; Konishi et al, 1996; Breivik et al, 1997; Losi
et al, 1997; Olschwang et al, 1997; Ruschoff et al, 1997; Forster
et al, 1998; Lukish et al, 1998; Yagi et al, 1998). 
Schistosomiasis with S. japonicum is associated with risk of
colorectal cancer in studies correlating incidence, prevalence
and/or mortality rates of the 2 diseases and in case–control studies
done mainly in China and Japan (Chen et al, 1981; International
Agency for Research on Cancer, 1994). Studies in Egypt showed
an average prevalence of S. haematobium of 7.8% in Upper Egypt
and 36.4% for S. mansoni in Lower Egypt in the respective
endemic areas (El-Khoby et al, 2000). Infection rates were higher
in children and adolescents and in males. 21% of young children in
the Nile Delta region had schistosomiasis in another study (Curtale
et al, 1998). We identified by histopathology a prevalence of 32%
in our resection specimens of colorectal carcinoma from 2 cancer
centres in Cairo and Lower Egypt, a rate comparable to the
general population. We also found associations between molecular
characteristics of colorectal carcinomas and infection. Although
our patient numbers are small, our results suggest that schistoso-
miasis is associated with microsatellite instability and with K-ras
mutation in Egyptian colorectal carcinomas (cluster 2 in Table 5),
favouring schistosomiasis as a factor influencing pathogenesis in
some cancers. This finding also indicates different molecular
mechanisms for these genetic changes than in Western patients. A
previous study has related the type of p53 mutation in rectal cancer
to schistosomiasis with S. japonicum (Zhang et al, 1998), but the
mechanisms resulting in the differing profiles of accumulated
genetic alterations in Egyptian and Western cancers remain
unexplained. 
The morphologic precursors to colorectal carcinoma in Egypt
have not been studied extensively. Flat adenomas have been char-
acterized as an important precursor to colorectal carcinoma
(Rembacken et al, 2000). These lesions have a low frequency of K-
ras gene mutation (Jass, 1995), as does dysplasia complicating
chronic inflammatory bowel disease in the form of ulcerative
colitis and Crohn colitis, in which MSI-H is relatively common
(Umetani et al, 1999). Our finding that K-ras gene mutation is
infrequent in Egyptian colorectal carcinomas unassociated with
schistosomiasis raises the possibility that the flat adenoma could
be an important precursor. 
Westernization of Egypt is occurring as the country develops
and is affecting young people first because they are more likely to
change lifestyle than older people (Rockhill and Giovannucci,
1999). The remarkable differences in molecular pathology as
compared to Western patients could result from inherent differences
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Table 5 Distribution of characteristics among clusters of Egyptian patients with colorectal carcinoma 
Prevalence of characteristic (%) 
First cluster Second cluster 
Characteristica (n = 17 patients) (n = 29 patients)
Demographics 
Age < 40 years 77 17 
Male sex 71 41 
Schistosomiasis 18 48 
Tumour histology 
Poor differentiation 100 45 
Glandular type 53 79
Mucinous type 71 21
Signet-ring cell type 88 4 
Molecular findings in tumour 
MSI-H 12 38 
MSI-L 18 7 
K-ras gene mutation 0 17 
aCharacteristics included in the cluster analysis which did not differentiate among the clusters were
anatomic site (colon vs rectum), residence (urban vs rural) and p53 gene product overexpression. 
Figure 4 Immunohistochemistry of p53 gene product in Egyptian colon
cancer. The poorly differentiated carcinoma has nuclear overexpression of
p53 gene product of the type seen with p53 gene mutation
BJOC 01-1838 1037-1046  1/10/01  11:55 am  Page 1043in sensitivity and molecular responses to Western lifestyle in
Egyptians (Rockhill and Giovannucci, 1999). Schistosomiasis
appears to be important in colorectal carcinogenesis in some cases.
The outcome of the search for germline predispositions, environ-
mental factors and gene-environment interactions that are respon-
sible for our observations will impact strategies for prevention as
well as advance knowledge of the pathways involved in the mole-
cular pathogenesis of colorectal carcinoma. 
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